Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol.
Fu Y, Estoppey D, Roggo S, Pistorius D, Fuchs F, Studer C, Ibrahim AS, Aust T, Grandjean F, Mihalic M, Memmert K, Prindle V, Richard E, Riedl R, Schuierer S, Weber E, Hunziker J, Petersen F, Tao J, Hoepfner D.
Fu Y, et al. Among authors: pistorius d.
Nat Commun. 2020 Jul 7;11(1):3387. doi: 10.1038/s41467-020-17221-5.
Nat Commun. 2020.
PMID: 32636417
Free PMC article.